These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36455792)

  • 1. Efficacy of Catheter Ablation for Atrial Fibrillation in Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis.
    Faraz F; Rehman MEU; Sabir B; Ghaffar A; Iftikhar A; Maqsood A; Ahmad Cheema H; Yasmin F; Aamir M; Ahmed MU; Asghar MS
    Curr Probl Cardiol; 2023 Mar; 48(3):101524. PubMed ID: 36455792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: a systematic review and meta-analysis.
    Zhao DS; Shen Y; Zhang Q; Lin G; Lu YH; Chen BT; Shi LS; Huang JF; Lu HH
    Europace; 2016 Apr; 18(4):508-20. PubMed ID: 26612881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: atrial fibrillation type determines the success rate.
    Derejko P; Polańska M; Chojnowska L; Michałowska I; Wójcik A; Piotrowicz E; Lech A; Kłopotowski M; Baranowski R; Przybylski A; Bilińska M; Sierpiński R; Walczak F; Szumowski L
    Kardiol Pol; 2013; 71(1):17-24. PubMed ID: 23348529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: a systematic review and meta-analysis.
    Providencia R; Elliott P; Patel K; McCready J; Babu G; Srinivasan N; Bronis K; Papageorgiou N; Chow A; Rowland E; Lowe M; Segal OR; Lambiase PD
    Heart; 2016 Oct; 102(19):1533-43. PubMed ID: 27234160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: impact of age, atrial remodelling, and disease progression.
    Di Donna P; Olivotto I; Delcrè SD; Caponi D; Scaglione M; Nault I; Montefusco A; Girolami F; Cecchi F; Haissaguerre M; Gaita F
    Europace; 2010 Mar; 12(3):347-55. PubMed ID: 20173211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of nonpharmacologic treatment of atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Bassiouny M; Lindsay BD; Lever H; Saliba W; Klein A; Banna M; Abraham J; Shao M; Rickard J; Kanj M; Tchou P; Dresing T; Baranowski B; Bhargava M; Callahan T; Tarakji K; Cantillon D; Hussein A; Marc Gillinov A; Smedira NG; Wazni O
    Heart Rhythm; 2015 Jul; 12(7):1438-47. PubMed ID: 25814420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcatheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy: Long-term results and clinical outcomes.
    Castagno D; Di Donna P; Olivotto I; Frontera A; Calò L; Scaglione M; Arretini A; Anselmino M; Giustetto C; De Ferrari GM; Cecchi F; Haissaguerre M; Gaita F
    J Cardiovasc Electrophysiol; 2021 Mar; 32(3):657-666. PubMed ID: 33428271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness and safety of transcatheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Gaita F; Di Donna P; Olivotto I; Scaglione M; Ferrero I; Montefusco A; Caponi D; Conte MR; Nistri S; Cecchi F
    Am J Cardiol; 2007 Jun; 99(11):1575-81. PubMed ID: 17531584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ablation of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy: Treatment Strategy, Characteristics of Consecutive Atrial Tachycardia and Long-Term Outcome.
    Dinshaw L; Münkler P; Schäffer B; Klatt N; Jungen C; Dickow J; Tamenang A; Schleberger R; Pecha S; Pinnschmidt H; Patten M; Reichenspurner H; Willems S; Meyer C
    J Am Heart Assoc; 2021 Feb; 10(3):e017451. PubMed ID: 33455428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catheter ablation of atrial fibrillation in hypertrophic cardiomyopathy: long-term outcomes and mechanisms of arrhythmia recurrence.
    Santangeli P; Di Biase L; Themistoclakis S; Raviele A; Schweikert RA; Lakkireddy D; Mohanty P; Bai R; Mohanty S; Pump A; Beheiry S; Hongo R; Sanchez JE; Gallinghouse GJ; Horton R; Dello Russo A; Casella M; Fassini G; Elayi CS; Burkhardt JD; Tondo C; Natale A
    Circ Arrhythm Electrophysiol; 2013 Dec; 6(6):1089-94. PubMed ID: 24114776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substrate and procedural predictors of outcomes after catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Bunch TJ; Munger TM; Friedman PA; Asirvatham SJ; Brady PA; Cha YM; Rea RF; Shen WK; Powell BD; Ommen SR; Monahan KH; Haroldson JM; Packer DL
    J Cardiovasc Electrophysiol; 2008 Oct; 19(10):1009-14. PubMed ID: 18479329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-year outcomes after catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Zheng S; Jiang W; Dai J; Li K; Shi H; Wu W; Liu X; He B; Qiu X; Song Z
    J Cardiovasc Electrophysiol; 2020 Mar; 31(3):621-628. PubMed ID: 31930545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: a European observational multicentre study.
    Creta A; Elliott P; Earley MJ; Dhinoja M; Finlay M; Sporton S; Chow A; Hunter RJ; Papageorgiou N; Lowe M; Mohiddin SA; Boveda S; Adragao P; Jebberi Z; Matos D; Schilling RJ; Lambiase PD; Providência R
    Europace; 2021 Sep; 23(9):1409-1417. PubMed ID: 33930121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy.
    Rowin EJ; Hausvater A; Link MS; Abt P; Gionfriddo W; Wang W; Rastegar H; Estes NAM; Maron MS; Maron BJ
    Circulation; 2017 Dec; 136(25):2420-2436. PubMed ID: 28916640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis.
    Ganesan AN; Shipp NJ; Brooks AG; Kuklik P; Lau DH; Lim HS; Sullivan T; Roberts-Thomson KC; Sanders P
    J Am Heart Assoc; 2013 Mar; 2(2):e004549. PubMed ID: 23537812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catheter Ablation of Atrial Fibrillation: An Overview for Clinicians.
    Mujović N; Marinković M; Lenarczyk R; Tilz R; Potpara TS
    Adv Ther; 2017 Aug; 34(8):1897-1917. PubMed ID: 28733782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catheter ablation versus medical therapy for patients with persistent atrial fibrillation: a systematic review and meta-analysis of evidence from randomized controlled trials.
    Chen C; Zhou X; Zhu M; Chen S; Chen J; Cai H; Dai J; Xu X; Mao W
    J Interv Card Electrophysiol; 2018 Jun; 52(1):9-18. PubMed ID: 29549512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of catheter ablation of atrial fibrillation in hypertrophied hearts - Comparison between primary and secondary hypertrophy.
    Müssigbrodt A; Kosiuk J; Koutalas E; Pastromas S; Dagres N; Darma A; Lucas J; Breithardt OA; Sommer P; Dinov B; Eitel C; Rolf S; Döring M; Richter S; Arya A; Husser D; Bollmann A; Hindricks G
    J Cardiol; 2015 Jun; 65(6):474-8. PubMed ID: 25113952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome of catheter ablation for atrial fibrillation in patients with apical hypertrophic cardiomyopathy.
    Chen X; Dong JZ; Du X; Wu JH; Yu RH; Long DY; Ning M; Sang CH; Jiang CX; Bai R; Wen SN; Liu N; Li SN; Xu ZY; Ma CS; Tang RB
    J Cardiovasc Electrophysiol; 2018 Jul; 29(7):951-957. PubMed ID: 29858872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left atrial wall thickness and outcomes of catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Hayashi H; Hayashi M; Miyauchi Y; Takahashi K; Uetake S; Tsuboi I; Yodogawa K; Iwasaki YK; Shimizu W
    J Interv Card Electrophysiol; 2014 Aug; 40(2):153-60. PubMed ID: 24763706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.